New Sproxil advisor: Egbe Osifo-Dawodu, MD
We are glad to announce that Egbe Osifo-Dawodu has joined our team of advisors at Sproxil. Egbe is a partner at Anadach Group which focuses on bringing innovative solutions to
Are you need IT Support Engineer? Free Consultant
We are glad to announce that Egbe Osifo-Dawodu has joined our team of advisors at Sproxil. Egbe is a partner at Anadach Group which focuses on bringing innovative solutions to
Are you wondering whether the drugs you have just picked up from your local pharmacy will kill you, save your life, or make your disease drug resistant? Counterfeiting is a
Counterfeit drugs are being labeled as one of the most dangerous terrorists by Wiltshire C.N. Johnson, the Registrar of the Pharmacy Board of Sierra Leone. He said that counterfeit drugs
Counterfeit drugs, including fake, substandard, adulterated or falsely labeled medicines, have become a growing threat to global health. The problem is especially serious in developing countries. Thousands of people die
Every day in some parts of the world, consumers have to face a key decision point. “Should I go for the red shoes or the blue ones? Wait for next
Sproxil has just been recognized by Unite For Sight, a leading NGO that has provided high-quality eye care to 1,000,000 medically underserved persons so far. To the admiration of many,
Drug serialization is the process of identifying a medicine with a unique serial number that can be shared with others if necessary. It helps to track the movement of drugs
Drug counterfeiting has reached a level that threatens to damage the entire medical system and pharmaceutical industry. Reuters recently reported that counterfeiting drugs are now $200 billion a year global
Contact:Amanda GriffithBumble PR 617-851-8335 (direct) [email protected] FOR IMMEDIATE RELEASE SPROXIL, INC. WINS BOSTON IBM SMARTCAMP EVENT Company Selected By Entrepreneurs, Investors and Industry Experts as City’s “Smartest” Start-Up Somerville, MA,
Catch our CEO on the U.S. Chamber of Commerce blog Chamber Post, with an introduction from Dr. Mark Esper, Executive Vice President, Global Intellectual Property Center, U.S. Chamber of Commerce. Dr.